Exponent reported a slight decrease in total revenues for Q3 2020, with a 3% decrease to $98.7 million. However, the company expanded EBITDA margin by 60 basis points. Net income decreased to $18.1 million, or $0.34 per diluted share.
Total revenues decreased by 3% to $98.7 million compared to the same quarter in 2019.
Revenues before reimbursements decreased by 2% to $93.5 million year-over-year.
Net income decreased to $18.1 million, or $0.34 per diluted share, compared to $19.6 million, or $0.36 per diluted share, in the same period of 2019.
EBITDA for the quarter was $26.0 million, flat compared to Q3 2019.
Exponent anticipates revenues before reimbursements to decline 12% to 15% in the fourth quarter, and expects EBITDA margin to decline 250 to 350 basis points from the 27.1% achieved in the fourth quarter of 2019.